Comment on SARS-CoV-2 genome and spike protein, COVID-19, and efficacy of vaccines

被引：0
|
作者：
Mungmunpuntipantip, Rujittika [1 ]
Wiwanitkit, Viroj [2 ,3 ]
机构：
[1] Private Acad Consultant, Bangkok, Thailand
[2] Chandigarh Univ, Ajitgarh, Punjab, India
[3] Joesph Ayobabalola Univ, Ikeji Arakeji, Nigeria
来源：
CIRUGIA Y CIRUJANOS | 2025年 / 93卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页数：129
相关论文
共 50 条
  • [41] Production of trimeric SARS-CoV-2 spike protein by CHO cells for serological COVID-19 testing
    Johari, Yusuf B.
    Jaffe, Stephen R. P.
    Scarrott, Joseph M.
    Johnson, Abayomi O.
    Mozzanino, Theo
    Pohle, Thilo H.
    Maisuria, Sheetal
    Bhayat-Cammack, Amina
    Lambiase, Giulia
    Brown, Adam J.
    Tee, Kang Lan
    Jackson, Philip J.
    Wong, Tuck Seng
    Dickman, Mark J.
    Sargur, Ravishankar B.
    James, David C.
    BIOTECHNOLOGY AND BIOENGINEERING, 2021, 118 (02) : 1013 - 1021
  • [42] Molecular characterization of COVID-19 therapeutics: luteolin as an allosteric modulator of the spike protein of SARS-CoV-2
    Alvarado, Walter
    Perez-Lemus, Gustavo R.
    Menendez, Cintia A.
    Bylehn, Fabian
    de Pablo, Juan J.
    MOLECULAR SYSTEMS DESIGN & ENGINEERING, 2022, 7 (01): : 58 - 66
  • [43] SARS-CoV-2 full length spike protein for COVID-19 vaccine development and diagnostic testing
    Richardson, Crystal
    Abhyankar, Mayuresh
    Bracaglia, Jillian
    Agah, Sayeh
    Schuhmacher, Zachary
    Smith, Bryan
    Wuenschmann, Sabina
    Petri, William, Jr.
    Chapman, Martin
    Pomes, Anna
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB152 - AB152
  • [44] Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
    Li, Yang
    Lai, Dan-yun
    Zhang, Hai-nan
    Jiang, He-wei
    Tian, Xiaolong
    Ma, Ming-liang
    Qi, Huan
    Meng, Qing-feng
    Guo, Shu-juan
    Wu, Yanling
    Wang, Wei
    Yang, Xiao
    Shi, Da-wei
    Dai, Jun-biao
    Ying, Tianlei
    Zhou, Jie
    Tao, Sheng-ce
    CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (10) : 1095 - 1097
  • [45] SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
    Ahmed M. Almehdi
    Ghalia Khoder
    Aminah S. Alchakee
    Azizeh T. Alsayyid
    Nadin H. Sarg
    Sameh S. M. Soliman
    Infection, 2021, 49 : 855 - 876
  • [46] SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
    Almehdi, Ahmed M.
    Khoder, Ghalia
    Alchakee, Aminah S.
    Alsayyid, Azizeh T.
    Sarg, Nadin H.
    Soliman, Sameh S. M.
    INFECTION, 2021, 49 (05) : 855 - 876
  • [47] SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
    Giovanni Salvatori
    Laura Luberto
    Mariano Maffei
    Luigi Aurisicchio
    Giuseppe Roscilli
    Fabio Palombo
    Emanuele Marra
    Journal of Translational Medicine, 18
  • [48] SARS-CoV-2 variants- Evolution, spike protein, and vaccines
    Chen, Kai-Wei K.
    Huang, Daniel Tsung-Ning
    Huang, Li -Min
    BIOMEDICAL JOURNAL, 2022, 45 (04) : 573 - 579
  • [49] Recombinant protein vaccines against SARS-CoV-2 Comment
    Gilbert, Sarah C.
    Lambe, Teresa
    LANCET INFECTIOUS DISEASES, 2021, 21 (10): : 1337 - 1338
  • [50] Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
    Firouzabadi, Negar
    Ghasemiyeh, Parisa
    Moradishooli, Fatemeh
    Mohammadi-Samani, Soliman
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 117
12345